Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Scales for Outcomes in Parkinson's Disease-COGnition (SCOPA-COG)


Acronym: SCOPA-COG

Authors: Marinus J, Visser M, Verwey NA, Verhey FRJ, Middelkoop HAM, Stiggelbout AM, van Hilten JJ

The SCales for Outcomes in PArkinson's disease-COGnition (SCOPA-COG) is a short, reliable and valid instrument for assessing cognitive function in PD. The SCOPA-COG consists of 10 items divided over four domains: memory (4 items); attention (2 items); executive function (3 items) and visuospatial function (1 item). Scores range from 0-43, with higher scores reflecting better performance.

The development of the SCOPA-COG is part of a larger research project, the SCales for Outcomes in PArkinson’s disease (SCOPA), in which practical and clinimetric sound instruments for all relevant regions in PD are selected or developed. The SCOPA instruments were originally developed in the Dutch language. 

Original PublicationView the Scale (PDF) | Testbook

To request permission to use this Rating Scale, please fill out a Permission Request Form.

Year Published: 2003

Last Updated: November 06, 2019

Instrument Type: ClinRO

Estimated Time to Complete: 10-15 minutes

Available Translations:

Related Publications:

Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Movment Disorders, 2010 Nov 15;25(15):2501-7.

Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P: Global scales for cognitive screening in Parkinson’s disease: Critique and recommendations. Movement Disorders, 2018 Feb. 33(2):208-218.

Martínez-Martín P, Frades-Payo B, Rodríguez-Blázquez C, Forjaz MJ, de Pedro-Cuesta J; Grupo Estudio Longitudinal de Pacientes con Enfermedad de Parkinson. Pyschometric attributes of Scales for Outcomes in Parkinson’s disease-cognition (SCOPA-COG) in Castillian language. Revista de Neurologia. 2008 Oct. 47(7):337-43.

Verbaan D, Jeukens-Visser M, Van Laar T, Van Rooden SM, Van Zwet EW, Marinus J, Van Hilten JJ. SCOPA-COG cut-off value for detection of Parkinson’s disease dementia. Movement Disorders 2011;26;1881-1886.

Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., … Anderson, T. J. (2010). The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology, 75(19), 1717–25. doi:10.1212/WNL.0b013e3181fc29c9

Isella, V., Mapelli, C., Morielli, N., Siri, C., De Gaspari, D., Pezzoli, G., … Appollonio, I. M. (2013). Diagnosis of possible Mild Cognitive Impairment in Parkinson’s disease: Validity of the SCOPA-Cog. Parkinsonism & Related Disorders, 19(12), 1160–1163. doi:10.1016/j.parkreldis.2013.08.008

Marras, C., Armstrong, M. J., Meaney, C. a, Fox, S., Rothberg, B., Reginold, W., … Duff-Canning, S. (2013). Measuring mild cognitive impairment in patients with Parkinson’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 28(5), 626–33. doi:10.1002/mds.25426

Camargo CHF, Tolentino ES, Bronzini A, Ladeira MA, Lima R, Schultz-Pereira GL, Young-Blood MR. Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease. Dement Neuropsychol 2016:10:344-50.

Isella V, Mapelli C, Morielli N, De Gaspari D, Siri C, Pezzoli G, Antonini A, Poletti M, Bonuccelli U, Picchi L, Napolitano A, Vista M, Veglia M, Piamarta F, Grassi F, Appollonio IM. Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog). Funct Neurol. 2013 Apr-May;28(2):121-5.

Serrano-Dueñas M, Calero B, Serrano S, Serrano M, Coronel P. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease. Mov Disord. 2010 Nov 15;25(15):2555-62.

Forjaz MJ, Frades-Payo B, Rodriguez-Blazquez C, Ayala A, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio longitudinal de pacients con enfermedad da Parkinson Group. Should the SCOPA-COG be modified? A Rasch analysis perspective. Eur J Neurol. 2010 Feb;17(2):202-7.

Martínez-Martín P, Frades-Payo B, Rodríguez-Blázquez C, Forjaz MJ, de Pedro-Cuesta J; Grupo Estudio Longitudinal de Pacientes con Enfermedad de Parkinson. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language]. Rev Neurol. 2008 Oct 1-15;47(7):337-43. Spanish.

Carod-Artal FJ, Martínez-Martin P, Kummer W, Ribeiro Lda S. Psychometric attributes of the SCOPA-COG Brazilian version. Mov Disord. 2008 Jan;23(1):81-7.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice